Metabolic Syndrome using Second-Generation AntipsychoticsMetabolic Syndrome using Second-Generation Antipsychotics

Woman affected by schizoaffective disorder being treated with Olanzapine 24 developed metabolic syndrome. For this reason, a switch to Aripiprazole, a 25 third-generation antipsychotic, was proposed, resulting in improvements in 26 metabolic parameters, quality of life, and subjective well-being.